Literature DB >> 30511181

The protective effect of myo-inositol on human thyrocytes.

Silvia Martina Ferrari1, Giusy Elia1, Francesca Ragusa1, Sabrina Rosaria Paparo1, Claudia Caruso1, Salvatore Benvenga2,3,4, Poupak Fallahi5, Alessandro Antonelli6.   

Abstract

Patients affected by autoimmune thyroiditis reached positive effects on indices of thyroid autoimmunity and/or thyroidal function, after following a treatment with selenomethionine (Se) alone, or Se in combination with Myo-inositol (Myo-Ins). Our purpose was to investigate if Myo-Ins alone, or a combination of Se + Myo-Ins, is effective in protecting thyroid cells from the effects given by cytokines, or hydrogen peroxide (H2O2). We assessed the interferon (IFN)-γ-inducible protein 10 (IP-10/CXCL10) secretion by stimulating primary thyrocytes (obtained from Hashimoto's thyroiditis or from control patients) with cytokines in presence/absence of H2O2. Our results confirm: 1) the toxic effect of H2O2 in primary thyrocytes that leads to an increase of the apoptosis, to a decrease of the proliferation, and to a slight reduction of cytokines-induced CXCL10 secretion; 2) the secretion of CXCL10 chemokine induced by IFN-γ + tumor necrosis factor alpha (TNF)-α has been decreased by Myo + Ins, both in presence or absence of H2O2; 3) no effect has been shown by the treatment with Se. Therefore, a protective effect of Myo-Ins on thyroid cells has been suggested by our data, which exact mechanisms are at the basis of this effect need to be furtherly investigated.

Entities:  

Keywords:  CXCL10; Cytokines; Hydrogen peroxide; Myo-inositol; Selenomethionine; Thyrocytes

Mesh:

Substances:

Year:  2018        PMID: 30511181     DOI: 10.1007/s11154-018-9476-x

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  69 in total

1.  Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Silvia Frascerra; Alda Corrado; Cinzia Pupilli; Giampaolo Bernini; Salvatore Benvenga; Ele Ferrannini; Poupak Fallahi
Journal:  Exp Cell Res       Date:  2011-04-30       Impact factor: 3.905

2.  CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Silvia Frascerra; Cinzia Pupilli; Caterina Mancusi; Maria Rita Metelli; Claudio Orlando; Ele Ferrannini; Poupak Fallahi
Journal:  J Clin Endocrinol Metab       Date:  2010-09-01       Impact factor: 5.958

3.  Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Silvia Frascerra; Fabio Galetta; Ferdinando Franzoni; Alda Corrado; Mario Miccoli; Salvatore Benvenga; Aldo Paolicchi; Ele Ferrannini; Poupak Fallahi
Journal:  Cytokine       Date:  2011-05-20       Impact factor: 3.861

4.  Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations.

Authors:  Roland Gärtner; Barbara C H Gasnier; Johannes W Dietrich; Bjarne Krebs; Matthias W A Angstwurm
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

5.  Increased oxidative product formation by peripheral blood polymorphonuclear leukocytes in human periodontal diseases.

Authors:  S Kimura; T Yonemura; H Kaya
Journal:  J Periodontal Res       Date:  1993-05       Impact factor: 4.419

6.  Antioxidant systems and lymphocyte proliferation in the horse, sheep and dog.

Authors:  Elisabetta Chiaradia; Alberto Gaiti; Lucia Scaringi; Paola Cornacchione; Pierfrancesco Marconi; Luca Avellini
Journal:  Vet Res       Date:  2002 Nov-Dec       Impact factor: 3.683

7.  Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets.

Authors:  P Y Benhamou; C Moriscot; M J Richard; O Beatrix; L Badet; F Pattou; J Kerr-Conte; J Chroboczek; P Lemarchand; S Halimi
Journal:  Diabetologia       Date:  1998-09       Impact factor: 10.122

8.  L-carnitine treatment in a seriously ill cancer patient with severe hyperthyroidism.

Authors:  Rene Chee; Ravin Agah; Roberto Vita; Salvatore Benvenga
Journal:  Hormones (Athens)       Date:  2014 Jul-Sep       Impact factor: 2.885

9.  Human Mig chemokine: biochemical and functional characterization.

Authors:  F Liao; R L Rabin; J R Yannelli; L G Koniaris; P Vanguri; J M Farber
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

10.  Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis.

Authors:  Maurizio Nordio; Raffaella Pajalich
Journal:  J Thyroid Res       Date:  2013-10-02
View more
  4 in total

1.  Immunoendocrinology: When (neuro)endocrinology and immunology meet.

Authors:  Christian A Koch; Alessandro Antonelli
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

Review 2.  Chemokines in hyperthyroidism.

Authors:  Silvia Martina Ferrari; Ilaria Ruffilli; Giusy Elia; Francesca Ragusa; Sabrina Rosaria Paparo; Armando Patrizio; Valeria Mazzi; Alessandro Antonelli; Poupak Fallahi
Journal:  J Clin Transl Endocrinol       Date:  2019-05-17

3.  The Association of Myo-Inositol and Selenium Contrasts Cadmium-Induced Thyroid C Cell Hyperplasia and Hypertrophy in Mice.

Authors:  Salvatore Benvenga; Antonio Micali; Antonio Ieni; Alessandro Antonelli; Poupak Fallahi; Giovanni Pallio; Natasha Irrera; Francesco Squadrito; Giacomo Picciolo; Domenico Puzzolo; Letteria Minutoli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

4.  Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies.

Authors:  Salvatore Benvenga; Silvia Martina Ferrari; Giusy Elia; Francesca Ragusa; Armando Patrizio; Sabrina Rosaria Paparo; Stefania Camastra; Daniela Bonofiglio; Alessandro Antonelli; Poupak Fallahi
Journal:  Nutrients       Date:  2020-05-08       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.